Jennifer Cook

Jennifer E.
Cook is currently an Independent Director at Jazz Pharmaceuticals Plc since 2020, an Independent Director at Denali Therapeutics, Inc. since 2018, a Director at BridgeBio Pharma LLC, a Director at Ambys Medicines, Inc. since 2020, a Director at Gyroscope Therapeutics Ltd. since 2020, an Independent Non-Executive Director at BridgeBio Pharma, Inc. since 2019, and Principal at Jennifer Cook Consulting.
Former roles include Chief Executive Officer & Director at GRAIL, Inc. from 2018 to 2019, Non-Executive Director at Gyroscope Therapeutics Holdings Plc from 2020 to 2022, Senior Vice President-Immunology & Ophthalmology at Genentech, Inc. from 2011 to 2013, Senior VP & Global Head-Clinical Operations at Roche Pharmaceuticals, Inc. in 2017, and Principal at Prizm Pharmaceuticals, Inc. Education includes undergraduate and graduate degrees from Stanford University and an MBA from Haas School of Business.